novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide oral factors in obesity Which Weight-Loss Drug Is Better:

However, NHS availability has been limited due to supply constraints and commissioning decisions, with many areas implementing waiting lists or restricting access to specialist weight management services

the FDA wants to incentivize manufacturers to ensure they have manufacturing capacity to meet demand so patients dont suffer if they fall short

There is also a cost and access angle

Microorganisms 8:1008 Dobri N, Oumarou EEN, Alimenti C, Ortenzi C, Luporini P, Vallesi A (2013) Methionine sulfoxide reduction in ciliates: Characterization of the ready-to-use methionine sulfoxide-R-reductase genes in Euplotes

Most of the GLP-1 medications slow gastric emptying and reduce appetite, which can lead to lower fluid intake

Minimally invasive Simple once-weekly injections , with little to no downtime